Metraipolis › archive › dc_d9002ea2b8d4

Dissolution Rate and Stability Improvement of Hydrochlorothiazide and Valsartan by Co-Amorphous Formulation — Europe PMC PMID:42820109

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42820109
DOI
10.1155/adpp/9387077
License (as archived)
solo-consultazione
Archived
2026-10-07T18:06:15.430Z
SHA-256 of the archived text
b5b06a6ea1f7de1e975e6fad2c95496a76f0c514a7abfd0b6db9b169a294fbf0
Stable URL of this page
https://metraipolis.com/documento/dc_d9002ea2b8d4

How to cite

Dissolution Rate and Stability Improvement of Hydrochlorothiazide and Valsartan by Co-Amorphous Formulation — Europe PMC PMID:42820109 — Europe PMC (en), https://europepmc.org/article/MED/42820109 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9002ea2b8d4 (Metraipolis archive dc_d9002ea2b8d4, sha256 b5b06a6ea1f7de1e975e6fad2c95496a76f0c514a7abfd0b6db9b169a294fbf0)
BibTeX
@misc{dcd9002ea2b8d4,
  title = {Dissolution Rate and Stability Improvement of Hydrochlorothiazide and Valsartan by Co-Amorphous Formulation — Europe PMC PMID:42820109},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42820109},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9002ea2b8d4; sha256 b5b06a6ea1f7de1e975e6fad2c95496a76f0c514a7abfd0b6db9b169a294fbf0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42820109. Agents can read the archived copy with the MCP tool read_document.